Treatment of organ transplant-related lymphoma

Research output: Contribution to journalArticle

Abstract

First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.

Original languageEnglish (US)
Pages (from-to)963-973
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume11
Issue number5
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Lymphoma
Lymphoproliferative Disorders
Transplants
Human Herpesvirus 4
Non-Hodgkin's Lymphoma
Immunosuppression
Therapeutics
Transplant Recipients

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Treatment of organ transplant-related lymphoma. / Swinnen, Lode.

In: Hematology/Oncology Clinics of North America, Vol. 11, No. 5, 1997, p. 963-973.

Research output: Contribution to journalArticle

@article{6df44e4825df473daac356835ff29bca,
title = "Treatment of organ transplant-related lymphoma",
abstract = "First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.",
author = "Lode Swinnen",
year = "1997",
doi = "10.1016/S0889-8588(05)70473-1",
language = "English (US)",
volume = "11",
pages = "963--973",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Treatment of organ transplant-related lymphoma

AU - Swinnen, Lode

PY - 1997

Y1 - 1997

N2 - First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.

AB - First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.

UR - http://www.scopus.com/inward/record.url?scp=0030886756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030886756&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(05)70473-1

DO - 10.1016/S0889-8588(05)70473-1

M3 - Article

C2 - 9336725

AN - SCOPUS:0030886756

VL - 11

SP - 963

EP - 973

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 5

ER -